Cadonilimab plus chemotherapy improves survival in recurrent or metastatic cervical cancer
1. Cadonilimab plus chemotherapy significantly improved progression-free survival in patients with...
Read More
chronic-disease
Dyslipidemia contributes to greater incidence of diabetic kidney disease
The ratio of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol is associated with diabetic kidney disease: A cross-sectional study 1. Each one-unit increase in Non-High-Density Lipoprotein...
Read More
Chronic health conditions and employment transition in childhood-cancer survivors
1. Compared to the general population, survivors of childhood cancer had a greater association...
Read More
1. Isaclimab significantly improved disease activity at 150 mg and 600 mg doses. 2. Adverse events...
Read More
Paretic limbs suffer greater loss of bone mineral density following stroke
1. BMD may differ on paretic and nonparetic sides in stroke patients with a history of falling and...
Read More
Molecular-guided therapy improves survival in unfavorable cancer of unknown primary
1. Patients in the MGT group reported a significantly greater progression-free survival than those...
Read More
Axonal injury may occur up to 9 years prior to symptom onset in multiple sclerosis
1. Multiple sclerosis patients can sustain axonal injury up to 9 years before symptom onset. 2....
Read More
Nivolumab plus Ipilimumab in MSI-High Metastatic Colorectal Cancer
1. Progression-free survival at 12 months was 79% with nivolumab/ipilimumab vs 21% with...
Read More
Use of certain biologics or disease modifying antirheumatic drugs may be associated with cancer risk
1. The use of rituximab, abatacept and Janus kinase inhibitors (JAKis) in individuals with...
Read More
Endometriosis and uterine fibroids associated with a greater risk of mortality due to gynecologic cancers
1. A history of endometriosis and uterine fibroids in women was associated with a greater risk of...
Read More
Amivantumab plus lazertinib improves survival in EGFR-mutated advanced NSCLC
1. In this randomized trial, amivantamab-lazertinib led to significantly longer progression-free...
Read More
#Visual Abstract: Invasive Treatment Strategies Did Not Improve Outcomes for Older Patients with Myocardial Infarction
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No...
Read More
Finerenone reduces heart failure events in patients with HFpEF
1. In this randomized controlled trial of patients with heart failure and mildly decreased or...
Read More
Cases of neurodevelopmental disorders caused by mutated lncRNA CHASERR
1. Three unrelated children were found to have a de novo deletion in the long non-coding RNA...
Read More
Adjuvant dabrafenib and trametinib improve survival in stage III melanoma
1. After almost 10 years of follow-up, adjuvant dabrafenib and trametinib improved relapse-free...
Read More
Early Ramucirumab/Paclitaxel vs Continuation of First-line Chemotherapy in Advanced HER2-negative Gastric/Gastroesophageal Cancer
1. Median PFS was 6.6 months in the switch maintenance group and 3.5 months in the control group...
Read More
Asciminib improves outcomes in chronic myeloid leukemia
1. In this randomized controlled trial, among adults diagnosed with chronic myeloid leukemia...
Read More
Hip replacement superior to resistance training in severe hip osteoarthritis
1. In this randomized controlled trial, total hip replacement (THR) was superior to resistance...
Read More
Leadless pacemaker in wireless communication with subcutaneous ICD meets performance goals
1. In this prospective study, the use of a leadless pacemaker that received wireless communication...
Read More
Stereotactic body radiotherapy is noninferior to hypofractionated radiotherapy for localized prostate cancer
1. In this randomized controlled trial, among patients with localized prostate cancer,...
Read More